Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 26 Aug 2025 – 20 Aug 2026, limited by Groww Nifty Next 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Groww Nifty Next 50 Index Fund | Nifty 50 |
|---|---|---|
| 26 Aug 2025 | ₹100.00 | ₹100.00 |
| 25 Sep 2025 | ₹102.23 | ₹100.72 |
| 25 Oct 2025 | ₹103.78 | ₹104.38 |
| 24 Nov 2025 | ₹101.76 | ₹105.05 |
| 24 Dec 2025 | ₹103.18 | ₹105.79 |
| 23 Jan 2026 | ₹99.14 | ₹101.36 |
| 22 Feb 2026 | ₹103.99 | ₹103.48 |
| 23 Mar 2026 | ₹92.04 | ₹91.10 |
| 22 Apr 2026 | ₹107.02 | ₹98.65 |
| 22 May 2026 | ₹104.62 | ₹95.98 |
| 21 Jun 2026 | ₹108.44 | ₹97.17 |
| 21 Jul 2026 | ₹109.15 | ₹97.88 |
| 20 Aug 2026 | ₹111.50 | ₹98.06 |
| Metric | Groww · Direct NAV ₹11.00 Very High risk ★★★★★ 1Y | Category median Index Funds · 375 funds |
|---|---|---|
| +11.50% | +5.66% | |
| — | +8.82% | |
| — | +9.15% | |
| — | +11.72% | |
| +11.50% | +7.67% | |
| +15.69% | — | |
| — | +12.67% | |
| — | +13.64% | |
| — | +12.84% | |
| Risk | ||
| 16.91% | 13.97% | |
| 0.30 | 0.24 | |
| 0.41 | 0.36 | |
| -14.33% | -16.12% | |
| Nifty 50 | — | |
| — | +0.84% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 97.2% | |
| 0.49% | 0.36% | |
| ₹9.01Cr | ₹177.09Cr | |
| None | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 54% | 35% | |
| Nikhil Satam | — | |
| 26 Aug 2025 | — | |
| 50 | — | |
| 32.1% | — | |
| 0.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.